Diabetes Mellitus Type II Clinical Trial
Official title:
A Multicenter, Non-Comparative, Open, Phase III Study to Evaluate the Efficacy and Safety of Insulin Glargine on Subjects With Type 2 Diabetes Mellitus
A multicenter, non-comparative, one arm, open, phase III study to evaluate the efficacy and safety of insulin glargine on subjects with Type 2 Diabetes Mellitus
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT02261545 -
The Effect of n-3 Fatty Acid Supplementation on Serum Levels, and Gene Expression of type2 Diabetes Patient
|
Phase 4 | |
| Completed |
NCT02028091 -
Diabetes Mellitus - A Diagnosis Trial by Means of Non Invasive Measurements
|
N/A | |
| Completed |
NCT01684813 -
VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to Prasugrel
|
Phase 4 | |
| Completed |
NCT01252524 -
Effect of Calcium Polycarbophil on Type II Diabetes Mellitus Control: a Randomized Double-blind Study
|
N/A | |
| Recruiting |
NCT01311401 -
Predictors of Future Type 2 Diabetes Mellitus in Circassians Minority in Israel
|
N/A | |
| Recruiting |
NCT01565096 -
Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy
|
Phase 4 | |
| Completed |
NCT00151697 -
LANN-study: Lantus, Amaryl, Novorapid, Novomix Study
|
Phase 3 | |
| Withdrawn |
NCT01453751 -
Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes
|
N/A | |
| Not yet recruiting |
NCT01775059 -
Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4
|
N/A | |
| Completed |
NCT01281098 -
Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.
|
Phase 2 | |
| Completed |
NCT01669473 -
A Primary Care, EHR- Based Strategy to Promote Safe and Appropriate Drug Use
|
N/A | |
| Completed |
NCT02036372 -
Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
|
N/A | |
| Completed |
NCT03258840 -
EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes Mellitus
|
N/A | |
| Active, not recruiting |
NCT01386801 -
Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana
|
N/A | |
| Completed |
NCT02144948 -
Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II
|
Phase 3 |